UB Paderborn / Katalog / Suche / in CDI

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

American journal of hematology, 2019-11, Vol.94 (11), p.1176-1184

2019

Link zum Volltext

Verfügbarkeit prüfen

Hypertension and Obesity and the Risk of Kidney Cancer in 2 Large Cohorts of US Men and Women

Hypertension (Dallas, Tex. 1979), 2014-05, Vol.63 (5), p.934-941

2014

Link zum Volltext

Verfügbarkeit prüfen

Complementing venous thromboembolism, a risky move

Blood, 2021-11, Vol.138 (21), p.2018-2019

Sanfilippo, Kristen M.

2021

Link zum Volltext

Verfügbarkeit prüfen

The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans

Journal of hematology and oncology, 2024-01, Vol.17 (1), p.3-4, Article 3

2024

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism and risk stratification in hematological malignancies

Thrombosis research, 2022-05, Vol.213, p.S16-S21

Sanfilippo, Kristen M.

2022

Link zum Volltext

Verfügbarkeit prüfen

TPO-RAs and ITP remission: cause or coincidence?

Blood, 2023-06, Vol.141 (23), p.2790-2791

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessing the risk of venous thromboembolism in multiple myeloma

Thrombosis research, 2020-07, Vol.191, p.S74-S78

Sanfilippo, Kristen M.

2020

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans

JNCI : Journal of the National Cancer Institute, 2016-11, Vol.108 (11), p.djw145

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma

Research and practice in thrombosis and haemostasis, 2022-01, Vol.6 (1), p.e12634-n/a, Article e12634

2022

Link zum Volltext

Verfügbarkeit prüfen

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment

Journal of clinical medicine, 2023-12, Vol.13 (1), p.96

2023

Link zum Volltext

Verfügbarkeit prüfen

Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy

Hematology, 2022-12, Vol.2022 (1), p.363

2022

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in multiple myeloma is associated with increased mortality

Research and practice in thrombosis and haemostasis, 2020-10, Vol.4 (7), p.1203-1210

2020

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation practice patterns in COVID‐19: A global survey

Research and practice in thrombosis and haemostasis, 2020-08, Vol.4 (6), p.969-983

2020

Link zum Volltext

Verfügbarkeit prüfen

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment

Research and practice in thrombosis and haemostasis, 2022-05, Vol.6 (4), p.e12740-n/a, Article e12740

2022

Link zum Volltext

Verfügbarkeit prüfen

Modest performance of risk-prediction models for anticoagulant-related bleeding in patients with chronic liver disease

Thrombosis research, 2024-05, Vol.237, p.138-140

2024

Link zum Volltext

Verfügbarkeit prüfen

Thrombosis and bleeding in hematological malignancy

Best practice & research. Clinical haematology, 2022-03, Vol.35 (1), p.101353-101353, Article 101353

2022

Link zum Volltext

Verfügbarkeit prüfen

Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma

Journal of the National Comprehensive Cancer Network, 2019-07, Vol.17 (7), p.840

2019

Link zum Volltext

Verfügbarkeit prüfen

Unanswered questions in cancer‐associated thrombosis

British journal of haematology, 2022-09, Vol.198 (5), p.812-825

2022

Link zum Volltext

Verfügbarkeit prüfen

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Blood advances, 2021-02, Vol.5 (3), p.872-888

2021

Link zum Volltext

Verfügbarkeit prüfen

Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population‐based retrospective cohort study

Journal of thrombosis and haemostasis, 2022-07, Vol.20 (7), p.1610-1617

2022

Link zum Volltext

Verfügbarkeit prüfen

Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data

Thrombosis research, 2015-04, Vol.135 (4), p.616-620

2015

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.2068-2081

2021

Link zum Volltext

Verfügbarkeit prüfen

Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2022-12, Vol.20 (12), p.3026-3038

2022

Link zum Volltext

Verfügbarkeit prüfen

Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases

Prostate cancer and prostatic diseases, 2023-12, Vol.26 (4), p.743-750

2023

Link zum Volltext

Verfügbarkeit prüfen

A real-world study of pneumonitis in non-small cell lung cancer patients receiving durvalumab following concurrent chemoradiation

Journal of thoracic disease, 2023-12, Vol.15 (12), p.6427-6435

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score

Hypertension and Obesity and the Risk of Kidney Cancer in 2 Large Cohorts of US Men and Women

Complementing venous thromboembolism, a risky move

The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans

Venous thromboembolism and risk stratification in hematological malignancies

TPO-RAs and ITP remission: cause or coincidence?

Assessing the risk of venous thromboembolism in multiple myeloma

Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans

Evaluation of the Khorana score for prediction of venous thromboembolism in patients with multiple myeloma

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment

Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy

Venous thromboembolism in multiple myeloma is associated with increased mortality

Anticoagulation practice patterns in COVID‐19: A global survey

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment

Modest performance of risk-prediction models for anticoagulant-related bleeding in patients with chronic liver disease

Thrombosis and bleeding in hematological malignancy

Derivation and Validation of a Risk Assessment Model for Immunomodulatory Drug-Associated Thrombosis Among Patients With Multiple Myeloma

Unanswered questions in cancer‐associated thrombosis

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Different risks of hemorrhage in patients with elevated international normalized ratio from chronic liver disease versus warfarin therapy, a population‐based retrospective cohort study

Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data

Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies—TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy

Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH

Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases

A real-world study of pneumonitis in non-small cell lung cancer patients receiving durvalumab following concurrent chemoradiation

Suchergebnisse filtern